BIO-key International (BKYI) Stock Price, News & Analysis

Company Overview

BIO-key International, Inc. (NASDAQ: BKYI) is a provider of biometric identity management and multi‐factor authentication solutions designed to secure access to digital resources. The company’s core business revolves around the development, marketing and support of fingerprint recognition hardware and software, as well as cloud‐based and on‐premise identity and access management (IAM) platforms. BIO-key’s suite of products enables organizations to replace or supplement traditional password systems with more secure, user‐friendly biometric authentication methods.

The company’s flagship offerings include biometric readers, software development kits (SDKs) and PortalGuard, a comprehensive IAM solution that integrates single sign‐on, multi‐factor authentication and self‐service credential management. BIO-key’s fingerprint readers are FIPS 201‐compliant and cater to enterprise IT, healthcare, government and financial services customers. Its cloud‐native and on‐premises deployment models provide flexibility, enabling clients to implement biometric security without overhauling existing infrastructure.

Founded in 1996 and headquartered in Farmingdale, New York, BIO-key International has expanded its reach through strategic partnerships and distribution agreements across North America, Europe and the Asia‐Pacific region. Over its history, the company merged with various technology firms to bolster its product portfolio and broaden its addressable market. Its publicly traded status since 2005 has supported ongoing investments in research and development, with a focus on mobile biometric applications and next‐generation authentication techniques.

Under the leadership of President and Chief Executive Officer Michael DePasquale IV, BIO-key has pursued growth through innovation and targeted acquisitions. Management emphasizes compliance with industry security standards and the delivery of scalable solutions that reduce password‐related help‐desk costs and strengthen overall cybersecurity posture. As demand for stronger identity verification intensifies, BIO-key continues to position itself as a specialist in frictionless, biometric‐first authentication technologies.

Key Stats

• Today's Range: $0.79 to $0.81
• 50-Day Range: $0.76 to $0.89
• 52-Week Range: $0.52 to $3.68
• Volume: 111,449 shs
• Average Volume: 2.33 million shs
• Market Capitalization: $4.66 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BIO-key International Stock Analysis - MarketRank™

BIO-key International scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for BIO-key International.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of BIO-key International is -0.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of BIO-key International is -0.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

BIO-key International has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.55% of the float of BIO-key International has been sold short.

Short Interest Ratio / Days to Cover

BIO-key International has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in BIO-key International has recently increased by 60.25%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

BIO-key International does not currently pay a dividend.

Dividend Growth

BIO-key International does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

5.55% of the float of BIO-key International has been sold short.

Short Interest Ratio / Days to Cover

BIO-key International has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in BIO-key International has recently increased by 60.25%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: N/A

News Sentiment

BIO-key International has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.86 average news sentiment score of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 1 news article for BIO-key International this week, compared to 1 article on an average week.

MarketBeat Follows

1 people have added BIO-key International to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, BIO-key International insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 3.70% of the stock of BIO-key International is held by insiders.

Percentage Held by Institutions

Only 26.51% of the stock of BIO-key International is held by institutions.

BKYI Stock Analysis - Frequently Asked Questions

How have BKYI shares performed this year?

BIO-key International's stock was trading at $1.71 at the start of the year. Since then, BKYI shares have decreased by 53.2% and is now trading at $0.8002.

How were BIO-key International's earnings last quarter?

BIO-key International Inc. (NASDAQ:BKYI) posted its earnings results on Thursday, May, 15th. The technology company reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.24) by $0.08. The technology company had revenue of $1.61 million for the quarter, compared to analysts' expectations of $1.30 million. BIO-key International had a negative net margin of 74.11% and a negative trailing twelve-month return on equity of 181.57%.
Read the conference call transcript.

When did BIO-key International's stock split?

BIO-key International shares reverse split on Thursday, December 21st 2023.The 1-18 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

How do I buy shares of BIO-key International?

Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BIO-key International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BIO-key International investors own include Exxon Mobil (XOM), Onconova Therapeutics (ONTX), T2 Biosystems (TTOO), Nokia (NOK), Electrameccanica Vehicles (SOLO), Tonix Pharmaceuticals (TNXP) and iBio (IBIO).

Company Calendar

• Last Earnings: 5/15/2025
• Today: 7/11/2025
• Next Earnings (Estimated): 8/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: ELEC PRODS - MISC
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:BKYI
• CIK: 1019034
• Web: www.bio-key.com
• Phone: (732) 359-1100
• Fax: 732-359-1101
• Employees: 50
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($2.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$4.30 million
• Net Margins: -74.11%
• Pretax Margin: -71.61%
• Return on Equity: -181.57%
• Return on Assets: -60.78%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.32
• Quick Ratio: 1.22

Sales & Book Value

• Annual Sales: $6.93 million
• Price / Sales: 0.67
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.02 per share
• Price / Book: 0.78

Miscellaneous

• Outstanding Shares: 5,820,000
• Free Float: 5,606,000
• Market Cap: $4.66 million
• Optionable: No Data
• Beta: 0.35